Robert Wood Johnson Foundation

Menu
  • About RWJF
  • Our Work
  • Research & Publications
View All:
  • Grants
  • Topics
  • Blogs

Industry Regulation

You are now viewing 1 - 10 of 27 results

Sort results by:
  • Relevance
  • Alphabetical Order
  • Publication Date

Search RWJF

  • Topic: Industry regulation
By Topic
  • Public policy and regulation (16)
  • Tobacco control (16)
  • Health promotion and disease prevention (16)
  • Prevention (15)
  • Tobacco cessation (15)
  • Addiction and substance abuse (15)
  • Behavior change (15)
  • Government, policy and legal issues (14)
  • Policy-makers (14)
  • Health policy (6)
  • Prescription drugs and services (5)
  • Physicians (4)
  • Health care system (3)
  • Care and services provided (2)
  • Competitions (1)
By Content
  • Content Type
    • Journal Article (23)
    • Program Result (2)
    • Story (1)
    • Blog Posts (1)
  • Program Area
    • Public Health (15)
    • Human Capital (11)
    • Enterprise Level (1)
By Demographics
  • Location
    • National (5)
  • States and Territories
    • Maine (ME) NE (1)
    • Minnesota (MN) WNC (1)
    • Vermont (VT) NE (1)

Impact of FDA Black Box Advisory on Antipsychotic Medication Use

January 11, 2010 | Journal Article

The 2005 US Food and Drug Administration (FDA) "black box" advisory warning that atypical antipsychotic drugs increased risk of death with elderly patients with dementia led to fewer mentions of the drugs by physicians in the four years after implementation of the drug label requirement.

Limiting the Influence of Pharmaceutical Industry Gifts on Physicians

January 1, 2010 | Journal Article

The medical profession and pharmaceutical industry have fallen short in reducing the influence of gifts on prescription practices through self-regulation. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession.

Biomarkers Unbound

June 21, 2012 | Journal Article

Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.

An Empirical Review of Major Legislation Affecting Drug Development

September 1, 2011 | Journal Article

Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.

Sex Cells: An RWJF Scholar Looks at the Market for Eggs and Sperm in this Country

February 14, 2012 | Human Capital Blog Post

Egg agencies are constantly thanking women for the wonderful difference they are making in the lives of recipients, so egg donors spoke with a great deal of pride about helping people have children. Some egg donors even described the money they rece ...

Can Tobacco Control Endgame Analysis Learn Anything From the U.S. Experience With Illegal Drugs?

May 1, 2013 | Journal Article

Tobacco control endgame strategies threaten to create large black markets with potential attendant harms.

Ending Tobacco-Caused Mortality and Morbidity

May 1, 2013 | Journal Article

Establishing performance standards for tobacco products is just one tool to reduce the death and disease caused by the use of these products.

Ending Versus Controlling Versus Employing Addiction in the Tobacco-Caused Disease Endgame

May 1, 2013 | Journal Article

Interest in reducing or eliminating tobacco-caused diseases is a common goal in tobacco control, but many experts hold different views on addition as a target of intervention.

In and Across Bureaucracy

May 1, 2013 | Journal Article

This article assesses the structural choices for the proposed tobacco endgame strategies.

Large-Scale Unassisted Smoking Cessation Over 50 Years

May 1, 2013 | Journal Article

Most smokers have been able to stop smoking without any formal assistance such as medication or professional assistance.

  • 1
  • 2
  • 3
  • Next
RWJF Home → Topics → Industry Regulation
  • Facebook
  • Twitter
  • YouTube
  • Email
  • RSS

Our mission: to improve the health and health care of all Americans.

  • About RWJF
    • Our Mission
    • Program Areas
    • From Our President
    • Leadership & Staff
    • Annual Reports
    • Newsroom
    • Job Opportunities
    • Office Location
    • Our Policies
  • Our Work
    • Health Policy
    • Prevention
    • Cost and Value
    • Leadership
    • All Topics
  • Program Areas
    • Childhood Obesity
    • Coverage
    • Human Capital
    • Pioneer
    • Public Health
    • Quality/Equality
    • Vulnerable Populations
  • Research & Publications
    • Find RWJF Research
    • Assessing Our Impact
    • How We Work
    • Data Center
    • RWJF DataHub
  • Grants
    • What We Fund
    • Calls for Proposals
    • Grantee Resources
    • FAQs
  • Blogs
    • Human Capital
    • New Public Health
    • Pioneering Ideas
  • My RWJF
    • Subscription Management
    • My Profile
  • Contact RWJF
  • Privacy Policy
  • Terms and Conditions

© 2001–2013 Robert Wood Johnson Foundation. All Rights Reserved.